Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Euronext Paris  >  Sanofi    SAN   FR0000120578

SANOFI (SAN)
Mes dernières consult.
Most popular
  Report  
Real-time Quote. Real-time Tradegate - 02/22 04:12:07 pm
64.53 EUR   -0.26%
02/20SANOFI : anofi diverting attention from real issues' -- Gordon
AQ
02/19SANOFI : Disclosure of trading in own shares
GL
02/19Stronger European Earnings Augur More M&A, Higher Dividends
DJ
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Sanofi to Cut 1,500-2,000 Jobs in France - Report

share with twitter share with LinkedIn share with facebook
share via e-mail
0
09/15/2012 | 02:11pm CET

French pharmaceutical giant Sanofi SA (SAN.FR, SNY) will disclose cuts of between 1,500 and 2,000 jobs in France on Sept. 25, French newspaper Le Figaro reported Saturday, without citing sources.

The company plans to reduce its 28,000 payroll in France mainly through attrition, the newspaper said.

In July, Sanofi had said it planned to cut jobs at two French units in a bid to preserve the company's profitability, which has been put at risk by recent patent expirations and the economic recession in most of Europe. The company had said it would detail the job cuts in September.

At the time, French Industry Minister Arnaud Montebourg had criticized the company and said he wouldn't tolerate when profitable companies slash jobs.

A Sanofi spokesman didn't return a phone call seeking comments.

Newspaper Web site: http://www.lefigaro.fr

Write to Inti Landauro at [email protected]

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

Valeurs citées dans l'article
ChangeLast1st jan.
SANOFI -0.12% 64.69 Delayed Quote.-10.04%
SANOFI -0.28% 64.53 Real-time Quote.-9.95%
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on SANOFI
02/21SANOFI : forms new alliance with CRN Greater Manchester
AQ
02/20SANOFI : anofi diverting attention from real issues' -- Gordon
AQ
02/20SANOFI : firm against full refund, financial aid to Dengvaxia recipients
AQ
02/20SANOFI : Manchester CRN gets Premier Site status from Sanofi
AQ
02/19SANOFI : Disclosure of trading in own shares
GL
02/19Stronger European Earnings Augur More M&A, Higher Dividends
DJ
02/17SANOFI : The USB mystery
AQ
02/17SANOFI : CRN Greater Manchester Named Sanofi UK Premier Site
AQ
02/16MYOKARDIA : Begins Patient Dosing in Phase 1b Clinical Study of MYK-491 in Dilat..
AQ
02/15Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial R..
AQ
More news
News from SeekingAlpha
07:15aACETO : Collapsing Generic Drug Pricing Brings Risk Of Covenant Violations 
02/21ROTY EDITION 1 VOLUME 81 : We Have A Launch Date! 
02/20BIOTECHS : Still Well Placed For More Gains 
02/202018 Brings New Challenges And Opportunities For Alnylam Pharmaceuticals 
02/19YOUR DAILY PHARMA SCOOP : AbbVie's Upadacitinib, Johnson & Johnson's Tremfya, Ce.. 
Financials (€)
Sales 2018 35 367 M
EBIT 2018 8 919 M
Net income 2018 5 324 M
Debt 2018 11 557 M
Yield 2018 4,73%
P/E ratio 2018 15,03
P/E ratio 2019 13,66
EV / Sales 2018 2,64x
EV / Sales 2019 2,46x
Capitalization 81 725 M
Chart SANOFI
Duration : Period :
Sanofi Technical Analysis Chart | SAN | FR0000120578 | 4-Traders
Technical analysis trends SANOFI
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 28
Average target price 83,0 €
Spread / Average Target 28%
EPS Revisions
Managers
NameTitle
Olivier Brandicourt Chief Executive Officer & Director
Serge Weinberg Chairman
Jérôme Contamine Chief Financial Officer & Executive VP-Finance
Elias A. Zerhouni President-Global Research & Development
Yong-Jun Liu Head-Global Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
SANOFI-9.95%100 242
JOHNSON & JOHNSON-6.33%349 006
NOVARTIS-2.67%224 221
PFIZER-0.58%213 155
ROCHE HOLDING LTD.-9.33%206 183
MERCK AND COMPANY-2.29%148 618